CLINICAL_TRIALS
withdrawal
· 2015-06-03
Clinical Trial Update: Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the Esophagus [Phase 2]
Summary
Clinical trial update shows a Phase 2 evaluation of a new covered metal stent for malignant esophageal lesions has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Weill Medical College of Cornell University | Conditions: Esophageal Cancer | Phase 2 | Status: WITHDRAWN